Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes

Mutation Research - DNA Repair

Volumn 408, Issue 3, 1998, Pages 203-218

  Hu, Yu ^a   Su, Lin ^a   Snow, Elizabeth T ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arsenic toxicity; DNA ligase activity; DNA repair enzyme

Indexed keywords

ARSENIC; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PYRUVATE DEHYDROGENASE;

ARTICLE; CARCINOGENESIS; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DNA REPAIR; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MUTAGENESIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

ARSENIC; CELLS, CULTURED; DNA LIGASES; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; ENZYME INHIBITORS; ENZYMES; ESCHERICHIA COLI; HUMANS; MUTAGENS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE;

EID: 0031697609     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(98)00035-4     Document Type: Article

References (80)

1. Bencko V. Carcinogenic, teratogenic, and mutagenic effects of arsenic. Environ. Health Perspect. 19:1977;179-182.
2. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmacol. Therapeut. 53:1992;31-65.
3. Cavigelli M., Li W.W., Lin A.N., Su B., Yoshioka K., Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15(22):1996;6269-6279.
4. Kowalski L.A., Tsang S.S., Davison A.J. Arsenic and chromium enhance transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells. Cancer Lett. 103(1):1996;65-69.
5. Germolec D.R., Spalding J., Boorman G.A., Wilmer J.L., Yoshida T., Simeonova P.P., Bruccoleri A., Kayama F., Gaido K., Tennant R., Burleson F., Dong W.M., Lang R.W., Luster M.I. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. Rev. Mutat. Res. 386(3):1997;209-218.
6. Chen G.Q., Shi X.G., Tang W.et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): 1. As2O3 exerts dose-dependent dual effects on APL cells. Blood. 89(9):1997;3345-3353.
7. Rossman T.G., Stone D., Molina M., Troll W. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ. Mutagen. 2:1980;371-379.
8. Lee T., Oshimura M., Barrett J. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis. 6(10):1985;1421-1426.
9. Li J., Rossman T. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Metals. 4(4):1991;197-200.
10. Delarosa M.E., Magnusson J., Ramel C., Nilsson R. Modulating influence of inorganic arsenic on the recombinogenic and mutagenic action of ionizing radiation and alkylating agents in Drosophila melanogaster. Mutat. Res., Rev. in Genetic Toxicol. 318(1):1994;65-71.
11. Lee T., Lee K., Tzeng Y., Huang R., Jan K. Sodium arsenite potentiates the clastogenicity and mutagenicity of DNA crosslinking agents. Environ. Mutagen. 8(1):1986;119-128.
12. Lee T., Huang R., Jan K. Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat. Res. 148(1-2):1985;83-89.
13. Wang T.S., Kuo C.F., Jan K.Y., Huang H.M. Arsenite induces apoptosis in chinese hamster ovary cells by generation of reactive oxygen species. J. Cell Physiol. 169(2):1996;256-268.
14. Nag J.K., Balaram V., Rubio R., Alberti J., Das A.K. Inorganic arsenic species in groundwater: a case study from Purbasthali (Burdwan) India. J. Trace Elem. Med. Biol. 10(1):1996;20-24.
15. Gubits R.M. c-fos mRNA levels are increased by the cellular stressors, heat shock and sodium arsenite. Oncogene. 3:1988;163-168.
16. Deaton M.A., Bowman P.D., Jones G.P., Powanda M.C. Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine and nitrogen mustard. Fundam. Appl. Toxicol. 14:1990;471-476.
17. Li G.C. Induction of thermotolerance and enhanced heat shock protein synthesis in Chinese hamster fibroblasts by sodium arsenite and ethanol. J. Cell Physiol. 115:1983;116-122.
18. Keyse S.M., Tyrrell R.M. Heme oxygenase is a major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA. 86:1989;99-103.
19. Kachinskas D.J., Phillips M.A., Qin Q., Stokes J.D., Rice R.H. Arsenate perturbation of human keratinocyte differentiation. Cell Growth Different. 5(11):1994;1235-1241.
20. Mivechi N.F., Koong A.C., Giaccia A.J., Hahn G.M. Analysis of HSF-1 phosphorylation in A549 cells treated with a variety of stresses. Int. J. Hyperthermia. 10(3):1994;371-379.
21. Huot J., Lambert H., Lavoie J.N., Guimond A., Houle F., Landry J. Characterization of 45-kDA/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27. Eur. J. Biochem. 227(1-2):1995;416-427.
22. Rossman T.G., Meyn M.S., Troll W. Effects of arsenite on DNA repair in Escherichia coli. Environ. Health Perspect. 19:1977;229-233.
23. Okada S., Yamanaka K., Ohba H., Kawazoe Y. Effect of inorganic arsenics on cytotoxicity and mutagenicity of ultraviolet light on Escherichia coli and the mechanism involved. J. Pharmacobio.-Dynam. 6(7):1983;496-504.
24. Snyder R., Lachmann P. Thiol involvement in the inhibition of DNA repair by metals in mammalian cells. Mol. Toxicol. 2(2):1989;117-128.
25. Lee-Chen S.F., Yu C.T., Jan K.Y. Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis. 7(1):1992;51-55.
26. Hartwig A., Groblinghoff U.D., Beyersmann D., Nataranjan A.T., Filon R., Mullenders L.H.F. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis. 18(2):1997;399-405.
27. Yager J.W., Wiencke J.K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat. Res. Rev. Mutat. Res. 386(3):1997;345-351.
28. Dong J., Luo X. Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts. Mutat. Res. 315(1):1994;11-15.
29. Lynn S., Shiung J.N., Gurr J.R., Jan K.Y. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radical Biol. Med. 24(3):1998;442-449.
30. Okui T., Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat. Res. 172(1):1986;69-76.
31. Yamanaka K., Hayashi H., Kato K., Hasegawa A., Oku N., Okada S. DNA single-strand breaks in L-132 cells resulting from inhibition of repair polymerization shortly after exposure to dimethylarsinic acid. Biol. Pharm. Bull. 20(2):1997;163-167.
32. Hartmann A., Speit G. Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells. Environ. Mol. Mutagen. 27(2):1996;98-104.
33. Jha A., Noditi M., Nilsson R., Natarajan A. Genotoxic effects of sodium arsenite on human cells. Mutat. Res. 284(2):1992;215-221.
34. Chao C.C.K. Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinum (II) induced DNA repair and drug resistance in HeLa cells. Environ. Toxicol. Pharmacol. 1(3):1996;199-205.
35. Lynn S., Lai H.T., Gurr J.R., Jan K.Y. Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis. 12(5):1997;353-358.
36. Li J.-H., Rossman T.G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2:1989;1-9.
37. Huang R.-N., Ho I.-C., Yih L.-H., Lee T.-C. Sodium arsenite induces chromosome endoreduplication and inhibits protein phosphatase activity in human fibroblasts. Environ. Mol. Mutagen. 25:1995;188-196.
38. Mitchell R.A., Change B.F., Huang C.H., DeMaster E.G. Inhibition of mitochondrial energy-linked functions by arsenate. Biochemistry. 10:1971;2049-2054.
39. Rein K.A., Borreback B., Bremer J. Arsenite inhibits oxidation in isolated rat liver mitochondria. Biochim. Biophys. Acta. 574:1979;487-494.
40. Little M.C., Gawkrodger D.J., Macneil S. Chromium- and nickel-induced cytotoxicity in normal and transformed human keratinocytes: an investigation of pharmacological approaches to the prevention of Cr(VI)-induced cytotoxicity. Br. J. Dermatol. 134:1996;199-207.
41. 6-methylguanine in a BamHI recognition site as substrate. Anal. Biochem. 205(2):1992;294-299.
42. Noguiez P., Barnes D., Mohrenweiser H., Lindahl T. Structure of the human DNA ligase I gene. Nucleic Acids Res. 20(15):1992;3845-3850.
43. Wei Y., Robins P., Carter K., Caldecott K., Pappin D., Yu G., Wang R., Shell B., Nash R., Schar P.et al. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol. Cell. Biol. 15(6):1995;3206-3216.
44. Vietor I., Vilcek J. Pathways of heat shock protein 28 phosphorylation by TNF in human fibroblasts. Lymphokine and Cytokine Res. 13(5):1994;315-323.
45. Zhang Z., Bai G., Deans-Zirattu S., Browner M.F., Lee E.Y.C. Expression of the catalytic sububunit of phosphorylase phospatase (protein phosphatase-1) in Escherichia coli. J. Biol. Chem. 267(3):1992;1484-1490.
46. Brown J.P., Perham R.N. Selective inactivation of the transacetylase components of the 2-oxo acid dehydrogenase multienzyme complexes of Escherichia coli. Biochem. J. 155:1976;419-427.
47. Fairlamb A., Smith K., Hunter K. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Mol. Biochem. Parasit. 53(1-2):1992;223-231.
48. Schiller C., Fowler B., Woods J. Effects of arsenic on pyruvate dehydrogenase activation. Environ. Health Perspect. 19:1977;205-207.
49. Stevenson K., Hale G., Perham R. Inhibition of pyruvate dehydrogenase multienzyme complex from Escherichia coli with mono- and bifunctional arsenoxides. Biochemistry. 17(11):1978;2189-2192.
50. Adamson S., Robinson J., Stevenson K. Inhibition of pyruvate dehydrogenase multienzyme complex from Escherichia coli with a radiolabeled bifunctional arsenoxide: evidence for an essential histidine residue at the active site of lipoamide dehydrogenase. Biochemistry. 23(6):1984;1269-1274.
51. Tkeshelashvili L.K., Shearman C.W., Zakour R.A., Koplitz R.M., Loeb L.A. Effects of arsenic, selenium, and chromium on the fidelity of DNA synthesis. Cancer Res. 40:1980;2455-2460.
52. Chirpich T. The effect of different buffers on terminal deoxynucleotidyl transferase activity. Biochim. Biophys. Acta. 518(3):1978;535-538.
53. 6-alkylguanine-DNA-alkyltransferase by metals. Mutat. Res. 192:1987;207-210.
54. 6-methylguanine-DNA methyltransferase. Carcinogenesis. 9(4):1988;683-685.
55. Li J.-H., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol. Trace Element Res. 21:1989;373-381.
56. 6-methyl guanine methyl transferase (MGMT) in post replication repair (PRR) deficient CHO-UV-1 cells: compensation for hypersensitivity to methylating and ethylating agents but not to mitomycin C. Somat. Cell Mol. Genet. 23(1):1997;9-17.
57. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50:1990;6119-6129.
58. Jeng J., Huh T.-L., Song B.J. Production of an enzymatically active E1 component of human pyruvate dehydrogenase complex in Escherichia coli: supporting role of E1b subunit in E1 activity. Biochem. Biophys. Res. Commun. 203(1):1994;225-230.
59. Dill K., Adams E., O'Connor R., McGown E. Structure and dynamics of a lipoic acid-arsenical adduct. Chem. Res. Toxicol. 2(3):1989;181-185.
60. Byrd D.M., Roegner M.L., Griffiths J.C., Lamm S.H., Grumski K.S., Wilson R., Lai S.H. Carcinogenic risks of inorganic arsenic in perspective. Int. Arch. Occup. Environ. Health. 68(6):1996;484-494.
61. Petres J., Baron D., Hagedorn M. Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ. Health Perspect. 19:1977;223-227.
62. Germolec D.R., Yoshida T., Gaido K., Wilmer J.L., Simeonova P.P., Kayama F., Burleson F., Dong W.M., Lange R.W., Luster M.I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141(1):1996;308-318.
63. Gonsebatt M.E., Vega L., Montero R., Garciavargas G., Delrazo L.M., Albores A., Cebrian M.E., Ostrosky-Wegman2 P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat. Res., Environ. Mutagen. and Related Subjects. 313(2-3):1994;293-299.
64. Gonsebatt M., Vega L., Herrera L., Montero R., Rojas E., Cebrian M., Ostrosky-Wegman P. Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat. Res. 283(2):1992;91-95.
65. Montecucco A., Savini E., Biamonti G., Stefanini M., Focher F., Ciarrocchi G. Late induction of human DNA ligase I after UV-C irradiation. Nucleic Acids Res. 23(6):1995;962-966.
66. Prigent C., Lasko D., Kodama K., Woodgett J., Lindahl T. Activation of mammalian DNA ligase I through phosphorylation by casein kinase II. EMBO J. 11(8):1992;2925-2933.
67. Guy G.R., Cairns J., Ng S.B., Tan Y.H. Inactivation of a redox-sensitive protein phosphatase during early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268(3):1993;2141-2148.
68. Corton J., Gillespie J., Hardie D. Role of the AMP-activated protein kinase in the cellular stress response. Current Biol. 4(4):1994;315-324.
69. Chen J., Martin B.L., Brautigan D.L. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science. 257:1992;1261-1264.
70. Liu Y.C., Huang H.M. Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell Biochem. 64(3):1997;423-433.
71. Kato K., Ito H., Okamoto K. Modulation of the arsenite-induced expression of stress proteins by reducing agents. Cell Stress Chaperones. 2(3):1997;199-209.
72. Bergelson S., Pinkus R., Daniel V. Intracellular glutathione levels regulate fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54:1994;36-40.
73. Wlodarczyk B., Bennett G.D., Calvin J.A., Craig J.C., Finnell R.H. Arsenic-induced alterations in embryonic transcription factor gene expression: implications for abnormal neural development. Dev. Genet. 18(4):1996;306-315.
74. Lu T.H., Pepe J.A., Gildemeister O.S., Tyrrell R.M., Bonkovsky H.L. Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures. Bba Gene Struct. Express. 1352(3):1997;293-302.
75. Chin K.V., Tanaka S., Darlington G., Pastan I., Gotesman M.M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 256:1990;221-226.
76. Guzzo A., Karatzios C., Diorio C., DuBow M.S. Metallothionein-II and ferritin H mRNA levels are increased in arsenite-exposed HeLa cells. Biochem. Biophys. Res. Commun. 205(1):1994;590-595.
77. Chen K., Wood T., He F., Narayan S., Wilson S. The bovine DNA polymerase beta promoter: cloning, characterization and comparison with the human core promoter. Gene. 164(2):1995;323-327.
78. Narayan S., He F., Wilson S.H. Activation of the human DNA polymerase beta promoter by a DNA-alkylating agent through induced phosphorylation of cAMP response element-binding protein-1. J. Biol. Chem. 271(31):1996;18508-18513.
79. Alaouijamali M., Mitra S. DNA repair and its regulatory pathways in cancer pharmacology. M.S. Med. Sci. 12(6-7):1996;766-773.
80. Grombacher T., Mitra S., Kaina B. Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis. 17(11):1996;2329-2336.